Barclays Rates Northrop Grumman (NOC) Underweight
Barclays has maintained its Underweight rating for Northrop Grumman, setting a price target of $419.00 as of October 9, 2026, a 18.59% downside from the current price.
Reviewed by automated data checks against the source data. How we make and check alerts
Barclays rated Northrop Grumman Corporation ($NOC) "Underweight" with a $419 price target on October 9, 2026.
Since the rating, $NOC is up 8.1% after 1 week and up 8.1% to date (from the $480.72 close on Oct 9, 2026).
Key Points
- Barclays has reiterated its Underweight rating on Northrop Grumman Corporation, setting a target price of $419.00.
- Barclays's $419 price target implies 18.59% downside from Northrop Grumman Corporation's ($NOC) current $514.70 share price.
- As of October 16, 2026, Northrop Grumman's stock is trading around $514.70, which is 22.8% above the analyst target.
- The stock is currently below its 50-day moving average by 2.4% and below its 200-day moving average by 13.4%.
Get $NOC trade alerts by text
We text you when insiders, Congress or big funds trade $NOC. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Northrop Grumman Corporation alert may contain errors. Disclosures
Barclays has reiterated its Underweight rating on Northrop Grumman Corporation (NYSE: NOC) on October 9, 2026, with a price target of $419.00. This marks a cautious stance on the aerospace and defense technology company, which operates through segments like Aeronautics Systems and Defense Systems.
Barclays' Call on Northrop Grumman
Barclays has maintained its Underweight rating on Northrop Grumman, setting a target price of $419.00. This is the first target set by Barclays for this stock, and it reflects the firm's outlook on the company's performance in the sector.
Other Institutional Activity in Northrop Grumman
Several other institutional investors have also adjusted their positions in Northrop Grumman. State Street Corporation increased its holdings by 167,719 shares, bringing its total to approximately 13.2 million shares worth about $6.8 billion. Blackrock Inc. added 901,090 shares, ending with about 11.8 million shares valued at around $6.1 billion. Meanwhile, Capital International Investors reduced its stake by 1,244,057 shares, now holding about 5.9 million shares worth about $3.0 billion.
Northrop Grumman Corporation Stock Up 3.8%
As of October 16, 2026, Northrop Grumman's stock is trading around $514.70, which is 22.8% above Barclays' target price. The stock is currently below both its 50-day and 200-day moving averages, indicating a potential downward trend, and it is also 33.5% below its 52-week high of $774.00.
$NOC price target
Northrop Grumman Corporation daily closes and this analyst's $419 target. Not advice.
Recent Earnings
Northrop Grumman reported trailing twelve-month revenue of approximately $42.9 billion, with a net margin of 10.5% and a return on equity of 27.0%. The next earnings report is scheduled for October 20, 2026.
Insider Buying and Selling at Northrop Grumman Corporation
Insider trading activity at Northrop Grumman shows several sales. Officer Roshan S. Roeder sold 1,754 shares at an average price of $720.00 on February 27, 2026, totaling about $1.26 million. General Counsel Kathryn G. Simpson sold 873 shares at $745.00 on March 2, 2026, for approximately $650,385. Director Mark A. Welsh III sold 95 shares on two occasions, totaling about $54,310 and $52,015.
Analysts Set New Price Targets
On October 9, 2026, Barclays reiterated its Underweight rating with a target price of $419.00. This follows various recent ratings, including a downgrade by RBC Capital to Sector Perform with a target of $525.00 and a Buy rating initiated by Rothschild & Co with a target of $680.00. The consensus among analysts is currently a Buy recommendation with a mean price target of approximately $619.08 from 24 analyst opinions.
About Northrop Grumman
Northrop Grumman Corporation is a major aerospace and defense technology company based in Falls Church, VA. It operates globally, providing advanced systems and services in areas like aeronautics and defense. The company's performance is closely watched, especially as it navigates a complex market.
Bottom Line
Investors should keep an eye on Northrop Grumman's upcoming earnings report on October 20, 2026. With Barclays' recent reiteration of its Underweight rating and a target price significantly below the current trading level, the market's response will be crucial to watch in the coming weeks.
Source: Barclays's rating change on $NOC (Oct 9, 2026). Written by software, not financial advice. How we make alerts
